Laddar...
Effective innate and adaptive anti-melanoma immunity through localized TLR-7/8 activation
Intratumoral immune activation can induce local and systemic anti-tumor immunity. Imiquimod is a cream-formulated, TLR-7 agonist that is FDA-approved for the treatment of non-melanoma skin cancers, but has limited activity against melanoma. We studied the anti-tumor activity and mechanism of action...
Sparad:
| Huvudupphovsmän: | , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4201984/ https://ncbi.nlm.nih.gov/pubmed/25252955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1401160 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|